199 results
424B3
RGBP
Regen BioPharma Inc
24 Apr 24
Prospectus supplement
1:28pm
for the marketing and sale of any of the Company’s products and therapies and no assurance may be given that any of the Company’s products or therapies … or, alternatively, advance the application further to Phase III clinical trials. The Company can provide no assurance that the Company will be able
424B3
RGBP
Regen BioPharma Inc
19 Jan 24
Prospectus supplement
1:29pm
of the Company’s products and therapies and no assurance may be given that any of the Company’s products or therapies will be granted such approval … the application further to Phase III clinical trials. The Company can provide no assurance that the Company will be able to sell or license any product
424B3
2yqiyr2zclcdoyti
20 Nov 23
Prospectus supplement
9:38am
424B3
EX-31.2
0r5azyab2xuxf
20 Nov 23
Prospectus supplement
9:38am
424B3
EX-31.1
0g1se5
20 Nov 23
Prospectus supplement
9:38am
424B3
60w0mje2xp
2 Oct 23
Prospectus supplement
1:42pm
8-K
EX-10.1
7gdslfs9
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm